3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
27
Prostatic Neoplasms
5
Osteosarcoma
5
Neuroendocrine Tumors
5
Neoplasms
5
Colorectal Neoplasms
5
Clear-cell metastatic renal cell carcinoma
5
Carcinoma, Hepatocellular
5
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Sarcoma, Ewing
3
Sarcoma
3
Neoplasm Metastasis
3
Kidney Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Medullary
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Small Cell Lung Carcinoma
2
Penile Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma
2
Adrenocortical Carcinoma
2
von Hippel-Lindau Disease
1
Wilms Tumor
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Interventions
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Epirubicin
2
pembrolizumab
1
lenvatinib
1
enfortumab vedotin
1
anlotinib
1
amivantamab
1
Pemetrexed
1
Observation
1
Ipilimumab
1
Imatinib Mesylate
1
Glutamate Carboxypeptidase II
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
BMS-906024
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
cabozantinib
×
90 days
×
Clear all
No trials found.